Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Use of once-weekly semaglutide in patients with type 2 diabetes in routine clinical practice: results from the SURE Canada multicentre, prospective, observational study
Sue Ojageer
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised place-bo-controlled trial
Data and documents, including the study protocol, statistical analysis plan, clinical study report, and blank or annotated case report forms, will be provided in a secure data sharing environment
Always disclose your full medication list with your licensed healthcare provider before starting semaglutide
Robledinos-Antn et al., 2019
US$ 26.89
US$ 25.71
US$ 24.01
